Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: Influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

Blood

Volumn 100, Issue 5, 2002, Pages 1611-1618

  Wagner, John E ^a,b   Barker, Juliet N ^a   DeFor, Todd E ^a   Scott Baker, K ^a   Blazar, Bruce R ^a   Eide, Cindy ^a   Goldman, Anne ^a   Kersey, John ^a   Krivit, William ^a   MacMillan, Margaret L ^a   Orchard, Paul J ^a   Peters, Charles ^a   Weisdorf, Daniel J ^a   Ramsay, Norma K C ^a   Davies, Stella M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HLA ANTIGEN; METHOTREXATE; METHYLPREDNISOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD GROUP ABO SYSTEM; CANCER THERAPY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HLA TYPING; HUMAN; INFANT; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; PRIORITY JOURNAL; RISK MANAGEMENT; SURVIVAL RATE; THROMBOCYTE; TRANSPLANTATION; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; WHOLE BODY RADIATION;

EID: 0036721158     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0294     Document Type: Article

References (50)

1. Allogeneic sibling donor umbilical-cord-blood transplantation in children with malignant and non-malignant disease
2. Outcome of cord-blood transplantation from related and unrelated donors
3. Outcomes among 562 recipients of placental blood transplants from unrelated donors
4. Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling
5. Placental blood as a source of hematopoietic stem cells for transplantation in unrelated recipients
6. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease
7. Current status of umbilical cord blood hematopoietic stem cell transplantation
8. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor umbilical cord blood transplantation
9. Hematopoietic engraftment and survival after unrelated donor umbilical cord blood transplantation in adult recipients
10. Unrelated marrow donor registries
11. Marrow transplantation from unrelated donors for the treatment of hematologic malignancies: Effect of mismatching for one HLA locus
12. Unrelated donor bone marrow transplant: Influence of HLA-A and B incompatibility on outcome
13. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation
14. Effect of HLA compatibility on graft-versus-host disease, relapse and survival after bone marrow transplantation for patients with leukemia or lymphoma
15. Graft-versus-host disease
16. Unrelated placental blood for bone marrow reconstitution: Organization of the placental blood program
17. Allogeneic umbilical cord blood transplantation
18. Unrelated donor cord blood transplantation for correction of genetic diseases
19. Histocompatibility
20. Ten HLA-DR4 alleles defined by sequence polymorphism within the DRB1 first domain
21. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow transplantation
22. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients: Results of a placebo-controlled, double-blind trial
23. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors
24. Non-parametric inference for cumulative incidence functions in competing risks studies
25. Nonparametric estimation from incomplete observations
26. Tests for trend in life table analysis
27. Regression models and life tables
28. Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients
29. Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation
30. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: Graft progenitor content is a better predictor than nucleated cell quantity
31. Hematopoietic engraftment and survival after unrelated donor umbilical cord blood transplantation in adult recipients
32. Engraftment and survival after unrelated donor transplantation: A report from the National Marrow Donor Program
33. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: Results of a matched-pair analysis
34. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia
35. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling
36. Risk factors for acute GVHD in children receiving unrelated donor BMT: Report of 2164 transplants from the National Marrow Donor Program (NMDP)
37. Evidence that umbilical cord blood contains a higher frequency of HLA class II specific alloreactive T cells than adult peripheral blood: A limiting dilution analysis
38. Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: Results of a phase I clinical trial
39. Bone marrow graft engineering by counterflow centrifugal elutriation: Results of a phase I-II clinical trial
40. Graft-versus-host disease prophylaxis for matched unrelated donor bone marrow transplantation: Comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone
41. Proliferative and cytotoxic responses of human umbilical cord blood T lymphocytes following allogeneic stimulation
42. Immune functions of cord blood cells before and after transplantation
43. Unrelated bone marrow transplantation in children: Outcome and a comparison with sibling donor grafting
44. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: The effect of leukemic burden, donor HLA matching, and marrow cell dose
45. Unrelated donor marrow transplantation in children
46. Graft selection in unrelated placental/umbilical cord blood (PCB) transplantation: Influence and weight of HLA match and cell dose on engraftment and survival
47. Factors associated with outcome after cord blood transplantation in children with acute leukemia